CAR T-Cell Therapy Available at Rutgers Cancer Institute and Robert Wood Johnson University Hospital

Between 60 to 70 percent of patients with aggressive non-Hodgkin lymphoma are cured with initial chemotherapy and a significant percentage of patients who relapse are cured with a stem cell transplant using the patient’s own cells. However, in patients whose disease becomes resistant to chemotherapy, the average survival is only six months. Until recently, those with B-cell lymphomas that did not respond to standard therapies had limited treatment options.

LGBTQ Health

.program-container { background-color: #e8f6fb; padding: 10px; color: #000000; } .program-title { font: bold 20px Arial,sans-serif; color: #1B7094; }

Educational Program Offerings

  • Prevention and Early Detection of HPV-Related Cancers for the LGBTQ Community
Research Leader Named to Rutgers Cancer Institute from National Cancer Institute to Build World-Class Cancer Immunology and Immunotherapy Programs
Protect Your Cervical Health
Make your Health a Priority in 2021
Subscribe to